Company News
Zydus Lifesciences Extends JV Investment Deadline to December 2026
Zydus Lifesciences provides regulatory update on its 50% equity investment in Zydus Sunshine Lifesciences joint venture.
Company and partner Sunshine Healthcare extend transaction completion deadline